Stock Price & Analysis

Based on the recent data and analyst coverage, here's a comprehensive analysis of WELL stock:

Technical Analysis

The stock is showing bullish momentum with strong support around $92 level. Recent price action indicates:

• Breaking above key resistance at $92.50
• Positive MACD crossover suggesting upward momentum
• RSI at 67.02 indicates room for further upside before becoming overbought

Fundamental Strength

The company demonstrates solid fundamentals:

• Revenue growth of 23.64% year-over-year
• Strong net margin of 22.37%
• Healthy debt-to-equity ratio of 0.53

Analyst Consensus

Recent analyst actions are overwhelmingly positive:

• Wedbush upgraded from Neutral to Outperform with $167 price target
• 6 analysts coverage with no bearish ratings
• Average price target of $161.67, with range of $141-$221
• Consensus shows 8.87% increase from previous average target

Key Growth Drivers

• Strong positioning in senior housing sector through holdings like Welltower
• Portfolio includes over 2,137 properties across healthcare sectors
• Geographic diversification with properties in US, Canada and UK
• Benefiting from aging demographics and healthcare demand growth

Recommendation: BUY

The combination of technical momentum, strong fundamentals, and positive analyst sentiment suggests WELL is well-positioned for continued upside. Entry around current levels with initial target of $161.67 (consensus) appears favorable.

Based on the provided data and market analysis, here's the price prediction for WELL stock in 2025:

Technical Analysis & Price Target The stock is currently trading at $150.06 with strong technical indicators showing an upward trend:

• RSI-14 at 67.02 indicates bullish momentum without being overbought
• MACD is positive at 4.91 with a bullish crossover (0.41 histogram)
• Stock is trading above all major moving averages (5-day: $149.88, 20-day: $143.06, 200-day: $121.71)

Analyst Consensus & Institutional Support According to recent analyst reports:

• Average price target: $152.21 (range: $126.25 - $232.05)
• Wedbush upgraded to "Outperform" in February 2025
• Strong institutional backing with 1,952 funds holding positions (3.01% increase)
• Put/call ratio of 0.60 indicates bullish sentiment

Fundamental Drivers Key catalysts supporting the price target:

• Expected FFO growth of 11.4% to $4.79 per share in 2025
• Strong Q4 2024 performance with FFO of $1.12 per share (16.7% YoY growth)
• Robust demand in Senior Housing Operating portfolio
• Strategic acquisitions driving revenue growth

Price Prediction for 2025 Based on technical analysis, analyst consensus, and fundamental factors, WELL stock is expected to reach $155-160 by end of 2025, representing a 3-7% upside from current levels. The prediction is supported by:

• Strong technical momentum
• Positive analyst sentiment
• Solid fundamental growth
• Institutional investor confidence

The S1 support level for WELL Stock is $143.62 ,The R1 resistant level for WELL Stock is $152.19.

As of the end of day on 2025-02-26, the price of WELL Stock was $152.

The target price for WELL Stock according to analyst rating is 157.11, with the highest price target at 242.00 and the lowest at 125.00. Analysts have a Strong Buy rating on WELL Stock overall.

The market cap of WELL is $97.3B.

Based on the provided data and recent analyst reports, I'll analyze whether WELL is overvalued through multiple perspectives:

Valuation Analysis:

• Current price of $92.31 (as of Feb 23, 2024) is significantly below the average analyst price target of $161.67, suggesting potential undervaluation
• Recent analyst upgrades from multiple firms including Wedbush raising target to $167 and B of A Securities setting a high target of $221

Technical Analysis:

• Stock showing strong momentum with RSI at 67.02, indicating bullish trend without being overbought
• MACD is positive at 4.91 with positive histogram (0.41), suggesting continued upward momentum
• Price trading above all major moving averages (5,10,20,60,200-day SMAs), indicating strong uptrend

Business Fundamentals:

• Revenue mix shows stable and growing core business with 71.62% from resident fees and services
• Strong market position with 2,137 diversified healthcare properties across senior housing, medical office, and skilled nursing sectors
• Net margin of 22.37% and ROE of 1.52% demonstrate solid profitability metrics

Growth Catalysts:

• Aging demographic trends support long-term demand growth
• Strategic portfolio positioning in high-growth markets
• Recent acquisitions and expansions strengthening market position

Based on these factors, WELL appears to be undervalued rather than overvalued at current levels.

Welltower Inc. is a real estate investment trust (REIT). The Company owns interests in properties concentrated in markets in the United States, Canada, and the United Kingdom (U.K.), consisting of seniors housing and post-acute communities and outpatient medical properties. The Company’s segments include Seniors Housing Operating, Triple-net and Outpatient Medical. The Seniors Housing Operating segment properties include senior apartments, assisted living, independent living/continuing care retirement communities, independent supportive living communities (Canada), care homes with and without nursing (U.K.), and combinations. The Triple-net segment invests in seniors housing and health care real estate through the acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases. The Company’s Outpatient Medical segment properties are leased to multiple tenants.

Based on the provided data and market analysis, here is the price prediction for WELL stock by 2030:

Welltower's stock price is projected to reach $220-250 by 2030, driven by strong demographic tailwinds in senior housing and healthcare real estate. The key factors supporting this prediction include:

Growth Drivers:

• Aging Baby Boomer population creating sustained demand for senior housing facilities
• Strategic expansion in medical office buildings and outpatient facilities
• Strong partnerships with leading healthcare operators
• Proven track record of dividend growth and capital appreciation

Current Position:

• Trading at $150.06 as of February 24, 2025
• Showing strong technical momentum with RSI at 67.02
• Above key moving averages (SMA 200 at $121.71)
• Institutional ownership increasing by 1.19% in recent quarters

Analyst Support:

• Recent upgrades from major firms like Wedbush and Scotiabank
• Average analyst price target of $161.67 with a high estimate of $221.00
• Strong buy ratings from majority of analysts covering the stock

Market Leadership:

• Largest healthcare REIT with diversified portfolio of 2,137 properties
• Strong presence in US, Canada and UK markets
• Focus on high-quality assets in major metropolitan areas
• Industry-leading operating margins and occupancy rates

The prediction assumes continued execution of management's growth strategy and no major disruptions to the healthcare real estate market. However, investors should note that long-term forecasts carry inherent uncertainties and actual results may differ materially.

WELL has a total of 533 employees.